Cancer BiologybioRxivPreprint
PI3Kβ inhibition restores ALK inhibitor sensitivity in ALK-rearranged lung cancer
K. Wennerberg, E. W. Verschuren, S. Talwelkar…·A. Knuuttila
The paper identifies PI3Kβ as a mediator of resistance to ALK inhibitors in ALK-rearranged lung cancer and shows that combining ALK and PI3Kβ inhibitors overcomes resistance.
DOI 10.1101/2021.03.18.435801